Treatment with the recently approved, minimally invasive Optilume BPH device improves urinary symptoms while preserving sexual function in men with benign prostatic hyperplasia (BPH), concludes a ...

"There's nothing else like Optilume BPH that's currently available, it's the only treatment option that requires no cutting, burning, steaming or implants," said Urotronic President and CEO David ...

August 10, 2023 – Treatment with the recently approved, minimally invasive Optilume BPH device improves urinary symptoms while preserving sexual function in men with benign prostatic hyperplasia (BPH) ...

LAS VEGAS -- A novel, non-ablative intervention for lower urinary tract symptoms (LUTS) produced rapid, durable symptom relief with no adverse effect on sexual function, long-term results from ...

The US Food and Drug Administration has approved a new catheter designed to treat urinary tract symptoms of an enlarged prostate, also known as benign prostate hyperplasia (BPH). Designed and marketed ...

Dr. Austen Slade, in Boise, Idaho, is proud to announce that he is the first urologist in the state to introduce the Optilume® BPH Catheter System. The Optilume technology has been a game changer.

Study demonstrates Optilume BPH treatment results in significant improvements immediately post procedure through one year; highest reported Qmax in BPH MIST trials MINNEAPOLIS, Aug. 30, 2023 ...

Dr. Steven A. Kaplan presented positive 4-year and 12-month clinical outcomes during the American Urological Association's Annual Meeting "The positive data from the PINNACLE and EVEREST trials – ...